Your browser doesn't support javascript.
loading
Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients.
Gong, Lei; He, Ronghui; Xu, Yanjun; Luo, Taobo; Jin, Kaixiu; Yuan, Wuzhou; Zheng, Zengguang; Liu, Lanxuan; Liang, Zebin; Li, Ao; Zheng, Zhiguo; Li, Hui.
Afiliação
  • Gong L; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) and Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • He R; Hangzhou YITU Healthcare Technology Co., Ltd., Hangzhou, China.
  • Xu Y; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) and Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Luo T; Department of Thoracic Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital) and Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Jin K; Hangzhou YITU Healthcare Technology Co., Ltd., Hangzhou, China.
  • Yuan W; Mingma Technologies Co., Ltd., Shanghai, China.
  • Zheng Z; Department of Pathology, Tthe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) and Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Liu L; Hangzhou YITU Healthcare Technology Co., Ltd., Hangzhou, China.
  • Liang Z; Hangzhou YITU Healthcare Technology Co., Ltd., Hangzhou, China.
  • Li A; Mingma Technologies Co., Ltd., Shanghai, China.
  • Zheng Z; Zhejiang Cancer Research Institute, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) and Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Li H; Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) and Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Thorac Cancer ; 12(15): 2170-2181, 2021 08.
Article em En | MEDLINE | ID: mdl-34128337
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antígenos de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Thorac Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Singapura
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antígenos de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Thorac Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Singapura